logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11103465 B1

PDFFull Text
Expired
Date of Patent:
Aug. 31, 2021

Filed:

Aug. 27, 2018

Trans-resveratrol topical medication for the treatment of pain and method of manufacture thereof

Applicant:

Ted's Brain Science, Inc., Dallas, TX (US);

Inventors:

Dennis I. Robbins, Dallas, TX (US);

David H. Hitt, Jr., Dallas, TX (US);

David H. Hitt, III, Dallas, TX (US);

Assignee:

Ted's Brain Science, Inc., Dallas, TX (US);

Attorneys:

Saul Ewing Arnstein & Lehr LLP

Domingos J. Silva

Dennis Ostrovsky

Primary Examiner:

Kortney L Klinkel

Assistant Examiner:

William Y Lee

Int. Cl.
CPC ...
A61K 31/05 (2006.01); A61K 31/245 (2006.01); A61K 47/10 (2017.01); A61K 47/06 (2006.01); A61K 33/38 (2006.01); A61K 31/125 (2006.01); A61P 31/00 (2006.01); A61K 47/12 (2006.01); A61K 31/606 (2006.01); A61K 31/196 (2006.01); A61K 31/45 (2006.01); A61K 31/167 (2006.01); A61K 47/02 (2006.01); A61K 31/47 (2006.01); A61K 9/10 (2006.01); A61P 25/00 (2006.01); A61K 31/573 (2006.01); A61K 31/18 (2006.01); A61K 31/7036 (2006.01); A61K 31/192 (2006.01); A61K 31/165 (2006.01); A61P 29/00 (2006.01); A61K 31/045 (2006.01); A61K 9/00 (2006.01); A61K 47/20 (2006.01); A61K 31/60 (2006.01);
U.S. Cl.
CPC ...
A61K 31/05 (2013.01); A61K 9/0014 (2013.01); A61K 31/045 (2013.01); A61K 31/125 (2013.01); A61K 31/165 (2013.01); A61K 31/167 (2013.01); A61K 31/18 (2013.01); A61K 31/192 (2013.01); A61K 31/196 (2013.01); A61K 31/245 (2013.01); A61K 31/47 (2013.01); A61K 31/573 (2013.01); A61K 31/60 (2013.01); A61K 31/606 (2013.01); A61K 31/7036 (2013.01); A61K 33/38 (2013.01); A61K 47/02 (2013.01); A61K 47/06 (2013.01); A61K 47/10 (2013.01); A61K 47/12 (2013.01); A61K 47/20 (2013.01); A61P 25/00 (2018.01); A61P 29/00 (2018.01); A61P 31/00 (2018.01);
Abstract

The invention provides a topical pain medication and a method of manufacturing and suing the same. In one embodiment, the medication includes: (1) enriched resveratrol having a concentration of trans-resveratrol therein that substantially exceeds the natural concentrations of trans-resveratrol in naturally occurring resveratrol, and (2) at least one inactive ingredient configured to mix with the resveratrol to form the topical medication. In one embodiment, the method includes: (1) processing resveratrol to increase the concentration of trans-resveratrol therein and (2) mixing at least one inactive ingredient with the resveratrol to form the topical medication.

Find Patent Forward Citations

Loading…